Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
Description
BACKGROUND: The 2016 World Health Assembly endorsed the elimination of hepatitis B virus (HBV) infection as a public health threat by 2030; existing therapies and prophylaxis measures make such elimination feasible, even in the absence of a
